Effect of adrenomedullin administration on acetic acid-induced colitis in rats

被引:38
作者
Ashizuka, S [1 ]
Ishikawa, N [1 ]
Kato, J [1 ]
Yamaga, J [1 ]
Inatsu, H [1 ]
Eto, T [1 ]
Kitamura, K [1 ]
机构
[1] Miyazaki Univ, Miyazaki Med Coll, Dept Internal Med 1, Miyazaki 8891692, Japan
关键词
acetic acid; adrenomedullin; colitis; inflammatory bowel disease; T helper 2 cells;
D O I
10.1016/j.peptides.2005.05.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Adrenomedullin (AM) administered intracolonically ameliorated the severity of acetic acid-induced colonic ulceration in rats. Ulcers were induced by subserosal injection of acetic acid into the colon. AM-treated group was administered 0.25-1.0 mu g of AM in 0.5 ml of saline intracolonically once a day; the control group received only saline. AM administration dose-dependently and significantly reduced the size of the ulcerative lesions, the associated edema, and the infiltration of the affected area by inflammatory cells. AM also reduced tissue levels of interleukin-6, but not interferon-gamma. AM reduces the severity of acetic acid-induced colitis in rats, probably by inhibiting the production and/or release of Th-2 cell-derived factors such as interleukin-6. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:2610 / 2615
页数:6
相关论文
共 35 条
  • [11] RENAL LOCALIZATION AND ACTIONS OF ADRENOMEDULLIN - A NATRIURETIC PEPTIDE
    JOUGASAKI, M
    WEI, CM
    AARHUS, LL
    HEUBLEIN, DM
    SANDBERG, SM
    BURNETT, JC
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 1995, 268 (04) : F657 - F663
  • [12] ADRENOMEDULLIN - A NOVEL HYPOTENSIVE PEPTIDE ISOLATED FROM HUMAN PHEOCHROMOCYTOMA
    KITAMURA, K
    KANGAWA, K
    KAWAMOTO, M
    ICHIKI, Y
    NAKAMURA, S
    MATSUO, H
    ETO, T
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 192 (02) : 553 - 560
  • [13] Kojima Ryotaro, 2001, Folia Pharmacologica Japonica, V118, P123, DOI 10.1254/fpj.118.123
  • [14] The inhibitory effect of adrenomedullin in the rat ileum:: Cross-talk with β3-adrenoceptor in the serotonin-induced muscle contraction
    Kravtsov, GM
    Hwang, ISS
    Tang, F
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2004, 308 (01) : 241 - 248
  • [15] Production of adrenomedullin in macrophage cell line and peritoneal macrophage
    Kubo, A
    Minamino, N
    Isumi, Y
    Katafuchi, T
    Kangawa, K
    Dohi, K
    Matsuo, H
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (27) : 16730 - 16738
  • [16] Adrenomedullin receptors: pharmacological features and possible pathophysiological roles
    Kuwasako, K
    Cao, YN
    Nagoshi, Y
    Kitamura, K
    Eto, T
    [J]. PEPTIDES, 2004, 25 (11) : 2003 - 2012
  • [17] Imbalance between interleukin-1 agonists and antagonists: relationship to severity of inflammatory bowel disease
    Ludwiczek, O
    Vannier, E
    Borggraefe, I
    Kaser, A
    Siegmund, B
    Dinarello, CA
    Tilg, H
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 138 (02) : 323 - 329
  • [18] EXPERIMENTAL PRODUCTION OF DIFFUSE COLITIS IN RATS
    MACPHERSON, BR
    PFEIFFER, CJ
    [J]. DIGESTION, 1978, 17 (02) : 135 - 150
  • [19] Fucoidan derived from Cladosiphon okamuranus Tokida ameliorates murine chronic colitis through the down-regulation of interleukin-6 production on colonic epithelial cells
    Matsumoto, S
    Nagaoka, M
    Hara, T
    Kimura-Takagi, I
    Mistuyama, K
    Ueyama, S
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2004, 136 (03) : 432 - 439
  • [20] Evaluating the antioxidant potential of new treatments for inflammatory bowel disease using a rat model of colitis
    Millar, AD
    Rampton, DS
    Chander, CL
    Claxson, AWD
    Blades, S
    Coumbe, A
    Panetta, J
    Morris, CJ
    Blake, DR
    [J]. GUT, 1996, 39 (03) : 407 - 415